New York Assembly Bill A02384

New York 2025-2026 Regular Session

• Introduced: 1/16/25
• Refer: 1/16/25
• Report Pass: 5/20/25
• Refer: 5/20/25
• Report Pass: 5/27/25

Caption

Requires insurers to provide insurance coverage for treatment of rare diseases, life-threatening conditions or diseases, degenerative and disabling conditions, or diagnoses involving medically fragile children, by a provider of the patient's choice.

Impact

The legislation significantly alters existing insurance coverage by mandating that health insurers provide coverage for treatments provided by out-of-network providers under certain conditions. Insurers must allow patients to choose any qualified provider as long as the costs are comparable to those within the in-network fee structure and a treating specialist recommends the chosen provider. It seeks to enhance healthcare access for individuals facing serious health challenges by eliminating restrictive network limitations, thereby fostering a more flexible treatment landscape.

Summary

A02384 aims to amend New York's insurance and public health laws to ensure that insurance policies cover medically necessary treatment for patients diagnosed with rare diseases, life-threatening conditions, degenerative and disabling conditions, or conditions involving medically fragile children. This bill emphasizes the right of patients to access medical services from a provider of their choice, irrespective of whether the provider is part of their health insurance plan's network.

Contention

The bill has spurred discussions surrounding the impact on the insurance landscape, particularly concerning the implications for insurance companies adhering to potential increased costs associated with broader coverage requirements. Supporters believe that the bill directly addresses the need for improved patient autonomy and access to specialized treatments, while critics may argue about the financial burden on insurers and potential impacts on overall healthcare costs. The balance between patient rights and insurance provider limitations remains a point of contention in legislative debates.